Issue Information (Adv. Therap. 2/2025).
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202570005
- Publication type:
- Article
Works matching IS 23663987 AND DT 2025 AND VI 8 AND IP 2
Results: 12
1
2
Self‐Assembled Nanocarriers of Synthetic and Natural Plasmalogens for Potential Nanomedicine Development (Adv. Therap. 2/2025).
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202570004
- By:
- Publication type:
- Article
3
Targeting ACAT1 for Precision Chemo‐Immunoprevention in Lung Cancer.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400430
- By:
- Publication type:
- Article
4
Synthetic Bilirubin‐Based Nanomedicine Alleviates Atopic Dermatitis by Reducing Oxidative Stress and Modulating Immune Responses.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400403
- By:
- Publication type:
- Article
5
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400400
- By:
- Publication type:
- Article
6
Targeting VEGF‐A in an Immunocompetent Orthotopic Mouse Model of Mesenchymal Glioblastoma Improves Antitumorigenicity and Decreases Proinflammatory Response in Normal Brain Tissue after Fractionated Radiotherapy.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400374
- By:
- Publication type:
- Article
7
Eltrombopag Inhibited Liver Cancer by Enhancing SMYD4 Protein Degradationvia TRIP12 Ubiquitinase.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400372
- By:
- Publication type:
- Article
8
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400370
- By:
- Publication type:
- Article
9
Disease‐Adaptive Drug Delivery to the Inflamed Intestinal Mucosa Using Poly(Lactic‐Co‐Glycolic Acid)‐cyclodextrin Hybrid Nanocarriers.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400368
- By:
- Publication type:
- Article
10
Therapeutic Effect of a Near‐Infrared Responsive MTX‐Mn<sub>3</sub>O<sub>4</sub>@PDA Nano‐Delivery System on Rheumatoid Arthritis.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400345
- By:
- Publication type:
- Article
11
Full Disappearance of PC3‐Luc Prostate Tumors Mediated by Hyperthermia Under Low Intensity Ultrasound Application in the Presence of Magnetosomes.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400281
- By:
- Publication type:
- Article
12
Self‐Assembled Nanocarriers of Synthetic and Natural Plasmalogens for Potential Nanomedicine Development.
- Published in:
- Advanced Therapeutics, 2025, v. 8, n. 2, p. 1, doi. 10.1002/adtp.202400093
- By:
- Publication type:
- Article